Shares of Precipio, Inc. (NASDAQ:PRPO – Get Free Report) crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $5.92 and traded as high as $6.70. Precipio shares last traded at $6.62, with a volume of 1,190 shares changing hands.
Precipio Stock Down 1.0 %
The stock has a market capitalization of $9.80 million, a price-to-earnings ratio of -2.70 and a beta of 1.41. The company has a debt-to-equity ratio of 0.03, a current ratio of 0.73 and a quick ratio of 0.59. The business has a fifty day moving average of $6.39 and a 200 day moving average of $5.92.
Precipio (NASDAQ:PRPO – Get Free Report) last announced its quarterly earnings results on Tuesday, August 13th. The biotechnology company reported ($0.83) EPS for the quarter. The business had revenue of $4.44 million during the quarter. Precipio had a negative net margin of 22.90% and a negative return on equity of 39.66%.
About Precipio
Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.
Featured Stories
- Five stocks we like better than Precipio
- Where to Find Earnings Call Transcripts
- Survey Reveals: America’s Most Coveted Businesses in 2024
- What Investors Need to Know About Upcoming IPOs
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- Election Stocks: How Elections Affect the Stock Market
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.
